Navigation Links
China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
Date:8/19/2007

molecule pharmaceutical products, including medicines, vaccines, and active pharmaceutical ingredients for various categories of diseases. CHBP's product portfolio includes 260 drugs already approved for manufacturing and marketing by the Chinese State Food and Drug Administration (SFDA). CHBP also has submitted 15 drug applications to the SFDA for its review during the calendar year of 2006. CHBP is a U.S.-listed public company with operating subsidiaries and senior management based in China. For further information, please visit our website at http://www.cbioinc.com .

Safe Harbor Statement

The statements contained herein that are not historical facts are "forward-looking statements" within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by, among other things, the use of forward-looking terminology such as "believes," "expects," "may," "will," "should," or "anticipates" or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy that involve risks and uncertainties. In particular, our statements regarding the potential growth of the markets are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including but not limited to, general economic conditions and regulatory developments, not within our control. The factors discussed herein and expressed from time to time in our filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed or implied by such statements. The forward-looking statements are made only as of the date of this filing, and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.


'/>"/>

SOURCE China Biopharmaceuticals Holdings, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. How do you level the playing field with China?
2. Speaker announces business members of IT Task Force
3. Doyle announces technology tax credits for Berbee
4. Doyle announces new energy, global warming policies
5. Doyle announces $80M renewable energy strategy
6. GE announces first installation of Discovery VCT
7. UWM announces winners of RGI awards
8. Third Wave announces two senior management appointments
9. Mirus announces new method for making antibodies
10. Merge announces sofware updates, upcoming acquisition
11. Small Tree announces ethernet solution for Apple Xserv G5
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... a leader in data visualization, today unveils a new ... hospital costs across the United States . The tool ... “Medicare Provider Charge Data,” a dataset of pricing information ... for Medicare & Medicaid Services. , The wide variation ... country has sparked considerable controversy; however, it is nearly ...
(Date:5/20/2013)... The World Molecular Imaging Society (WMIS) ... Baird as Executive Director. Baird will assume leadership ... The WMIS vision is to encompass and promote preclinical ... treat diseases in the developed and developing world. ... 2011 by integrating the Academy of Molecular Imaging and ...
(Date:5/19/2013)... The JM Internet Group (web: jm-seo.org), ... proudly announced that the company's YouTube channel on ... views on YouTube. The company uses YouTube as a ... and training for small businesses with much success. , ... tips helpful for their SEO strategies", explained Jason McDonald, ...
(Date:5/17/2013)... Dr. Sparano is Professor of Medicine ... the Albert Einstein College of Medicine and Associate Chairman ... Center. He is also Associate Director for Clinical ... Einstein Breast Cancer Working Group, a multidisciplinary group of ... He also serves as Vice Chair of the National ...
Breaking Biology Technology:Kitware Enables Interactive Exploration of CMS Medicare Data 2WMIS Appoints Lisa Baird as Next Executive Director 2YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 3
... - Global Advocacy Groups Launch Joint Effort to ... new international survey reveal that eye exams are being,ignored by ... visited an,eye specialist in the last year to have their ... compared to heart disease or early,death. The survey showed that ...
... the sabre-toothed cat Smilodon ranks alongside Tyrannosaurus rex as ... like knives, Smilodon was a fearsome predator of Ice-Age ... years, scientists have debated how this iconic predator used ... new Australian study, published today in the US Proceedings ...
... today that,the company,s Carlsbad, CA, CLIA laboratory operation ... The laboratory offers,two new molecular oncology tests to ... ID(TM) is a 92-gene expression assay capable of ... molecular classification of metastatic,cancer and guides the physician ...
Cached Biology Technology:International Survey Shows People Over Forty Ignore Risk of Blindness 2International Survey Shows People Over Forty Ignore Risk of Blindness 3International Survey Shows People Over Forty Ignore Risk of Blindness 4International Survey Shows People Over Forty Ignore Risk of Blindness 5Scientists say sabercat bit like a pussycat 2AviaraDx Announces CAP Accreditation of Its Laboratory Operations 2
(Date:5/20/2013)... colistin are also commonly resistant to antimicrobial substances ... study in mBio , the online open-access ... to colistin and host antimicrobials LL-37 and lysozyme, ... could mean that patients with life-threatening multi-drug resistant ... response. Colistin is a last-line drug for treating ...
(Date:5/20/2013)... - A National Science Foundation (NSF) planning grant will ... (CARD), a joint program of the University of Illinois ... Mass. , "CARD will be devoted to research in ... agricultural products; forestry and paper products; chemical products; textiles; ... professor of food science and human nutrition and the ...
(Date:5/19/2013)... that can grow using hydrogen gas as its sole ... of carbon. Researchers at the University of Massachusetts, ... of the American Society for Microbiology. , "This represents ... says Amit Kumar, a researcher on the study who, ... Lab Group at the university. , Under the leadership ...
Breaking Biology News(10 mins):Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3NSF approves planning grant for Center for Advanced Research in Drying 2
... Johns Hopkins scientists have discovered that a deceptively simple ... natural life cycle. , The discovery reveals that, when ... diseases by failing to properly control the steps and ... are described in the Sept. 23 issue of the ...
... be an early step in the development of sporadic colorectal ... may ultimately be useful in risk assessment for colorectal cancer, ... of the Journal of the National Cancer Institute. ... a "field defect", cells that appear normal but that have ...
... may be mass produced at a lower cost, ... compositions than ever before, for dramatic improvements in ... structures. These entirely new biologically-enabled approaches are detailed ... of Applied Ceramic Technology, published on behalf of ...
Cached Biology News:Sugar helps control cell division 2Sugar helps control cell division 3Change in gene may be underlying molecular defect in some colorectal cancers 2
For cleavage of 6xHis tags from proteins containing a Factor Xa Protease recognition site Efficient 6xHis tag cleavage (greater than 90%), ...
... PBL's bioassays for interferons are cytopathic effect inhibition ... Sample types include; tissue culture supernatents; serum ... these assays, one unit is defined as the ... the cytopathic effect of viral infection by 50%. ...
... effect inhibition assays, also known as CPE and ... supernatents; serum from PK studies and delivery formulations. ... as the quantity of interferon required per milliliter ... by 50%. All standards used in ...
... effect inhibition assays, also known as CPE and ... supernatents; serum from PK studies and delivery formulations. ... as the quantity of interferon required per milliliter ... by 50%. All standards used in ...
Biology Products: